Agile Therapeutics | AGRX - Stock


Agile Therapeutics reported $1.33M in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
Adma Biologics USD 222.1M 15.63M Mar/2026
Bayer EUR 12.34B 3M Dec/2025
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Cipla INR 61.6B 5.18B Sep/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
Grifols EUR 3.56B 63.19M Dec/2024
J&J USD 14.58B 392M Mar/2026
Merck USD 6.48B 179M Mar/2026
Pacira USD 150.37M 2.49M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
TherapeuticsMD USD 6.7M 551K Sep/2022